Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goska Leslie

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
JCO Precision Oncology|September 26, 2025
Incorporating Continuous Mammographic Density Into the BOADICEA Breast Cancer Risk Prediction ModelLorenzo Ficorella, Mikael Eriksson, Kamila Czene, et al.
Journal of Medical Genetics|September 26, 2022
Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort studyXin Yang, Mikael Eriksson, Kamila Czene, et al.
British Journal of Cancer|March 30, 2026
Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysisNasim Mavaddat, Daniel R Barnes, Kyriaki Michailidou, et al.
Journal of Medical Genetics|May 7, 2018
Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort studyXin Yang, Goska Leslie, Aleksandra Gentry-Maharaj, et al.
European Urology|December 12, 2018
Homeobox B13 G84E Mutation and Prostate Cancer RiskTommy Nyberg, Koveela Govindasami, Goska Leslie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2022
CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate CancerTommy Nyberg, Mark N Brook, Lorenzo Ficorella, et al.
Journal of Medical Genetics|November 30, 2021
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factorsAndrew Lee, Xin Yang, Jonathan Tyrer, et al.
NPJ Breast Cancer|September 30, 2025
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriersMei-Chee Tai, Joe Dennis, Sue K Park, et al.
Human Mutation|June 19, 2019
The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countriesYael Laitman, Tara M Friebel, Drakoulis Yannoukakos, et al.
NPJ Breast Cancer|September 23, 2020
Association of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancerTaru A Muranen, Sofia Khan, Rainer Fagerholm, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
JCO Precision Oncology|September 26, 2025
Incorporating Continuous Mammographic Density Into the BOADICEA Breast Cancer Risk Prediction ModelLorenzo Ficorella, Mikael Eriksson, Kamila Czene, et al.
Journal of Medical Genetics|September 26, 2022
Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort studyXin Yang, Mikael Eriksson, Kamila Czene, et al.
British Journal of Cancer|March 30, 2026
Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysisNasim Mavaddat, Daniel R Barnes, Kyriaki Michailidou, et al.
Journal of Medical Genetics|May 7, 2018
Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort studyXin Yang, Goska Leslie, Aleksandra Gentry-Maharaj, et al.
European Urology|December 12, 2018
Homeobox B13 G84E Mutation and Prostate Cancer RiskTommy Nyberg, Koveela Govindasami, Goska Leslie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2022
CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate CancerTommy Nyberg, Mark N Brook, Lorenzo Ficorella, et al.
Journal of Medical Genetics|November 30, 2021
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factorsAndrew Lee, Xin Yang, Jonathan Tyrer, et al.
NPJ Breast Cancer|September 30, 2025
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriersMei-Chee Tai, Joe Dennis, Sue K Park, et al.
Human Mutation|June 19, 2019
The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countriesYael Laitman, Tara M Friebel, Drakoulis Yannoukakos, et al.
NPJ Breast Cancer|September 23, 2020
Association of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancerTaru A Muranen, Sofia Khan, Rainer Fagerholm, et al.
Pageof 5